Cogstate Ltd ( (AU:CGS) ) just unveiled an announcement.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program. As of April 22, 2025, the company has bought back a total of 4,772,452 ordinary fully paid securities, with 3,341 securities acquired on the previous day. This buy-back initiative reflects Cogstate’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides cognitive assessment services and tools, primarily targeting the pharmaceutical, healthcare, and research markets.
YTD Price Performance: 23.11%
Average Trading Volume: 11,928
Technical Sentiment Signal: Sell
Current Market Cap: $140.9M
For an in-depth examination of CGS stock, go to TipRanks’ Stock Analysis page.